We are live on ! Find out more
RGN

REGENERX BIOPHARMACEUTICALS
RGN

Delisted

RGN was delisted on the 22nd of December, 2010.

Back to rankings

1 hedge funds and large institutions have $12K invested in REGENERX BIOPHARMACEUTICALS in 2014 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more capital invested

Capital invested by funds: $3K → $12K (+$9K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DBIA
1
Dumont & Blake Investment Advisors
New Jersey
$12K – – –

RGN Hedge Fund Activity: Q1 2014 in Review

1 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in REGENERX BIOPHARMACEUTICALS (RGN) for Q1 2014, worth a combined $12K — up 300% from $3K a quarter earlier.

Fund positioning in RGN was balanced in Q1 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held REGENERX BIOPHARMACEUTICALS (RGN) as of Q1 2014, unchanged from Q4 2013.
  • Funds reported $12K of REGENERX BIOPHARMACEUTICALS stock for Q1 2014, up 300% quarter-over-quarter.
  • 0 funds opened new REGENERX BIOPHARMACEUTICALS positions in Q1 2014 and 0 closed out.

Based on aggregated 13F filings for Q1 2014.